Top Tweets for #RayzeBio
📣 The Sponsors Sessions at the 2nd Symposium on Molecular Radiotherapy Dosimetry in #Athens took place this afternoon, giving attendees a great chance to connect with our industry partners. Thank you to everyone who joined!
#ITM #BlueEarthTherapeutics #BMS #RayzeBio

PCI Indianapolis delivered expert cleanroom work at RayzeBio’s new facility, including modular ceilings, walls & windows. These precision-built systems support critical life sciences work. Great job, team! ➡️ https://t.co/1zJKaX04yn #PCIproud #Cleanroom #RayzeBio

買収を完了。
◆2024年2月5日– ノバルティスが抗がん剤開発者 #MorphoSyoSources の買収で主導権を握る
◆2023年12月26日– ブリストル・マイヤーズ スクイブ社が #RayzeBio を41億ドル(104%のプレミアム)で買収する意向を発表。
◆2023年11月22日– ベーリンガーインゲルハイムは細菌性がん治療の
Es gab mehrere Interessenten für $RYZB #Rayzebio. Dieser M&A-Deal und die Akquisition von $PNT durch $LLY unterstreichen das große Interesse der Pharma-Branche am Radiopharma-Markt. Gutes Umfeld für #EckertundZiegler und die weiteren Pläne für #Pentixapharm. @s@schroeder1234 @VolkerGlaser1 @l_m_s15
Good gamemanship by $RYZB. IF $BMY had known 48 was the biggest offer..

RayzeBio brought a new therapy to the clinic to benefit patients with neuroendocrine tumors - @DrPhilKantoff
#Cancer #NeuroendocrineTumors #CancerTherapy #OncoDaily #Oncology #RayzeBio
https://t.co/hV6zQjkTqg
Das ist übrigens die Pipeline von #RayzeBio (Stand Nov 23) - der Firma für die Bristol Myers Squibb gerade 4,1 Mrd. USD bietet nachdem zum IPO im September von Investoren bereits eine Bewertung von knapp 1 Mrd. USD gezahlt wurde.
https://t.co/BD3AIzqDnZ

In a bold move to enhance its #oncology portfolio #Bristol Myers Squibb has announced the #acquisition of #RayzeBio for approximately $4.1 billion. This acquisition marks #BMS's second major deal in a week following its $14 billion buyout of Karuna... https://t.co/sez5moW99a
I hope this is good news for #Neuroendocrine tumor patients @Netespana The willing and effort behind #RayzeBio is going to be difficult to beat. @GrupoGetne @Ja_Capdevila https://t.co/uG1xe2xAI9
Wow: $BMY greift nach Radiopharma-Spezialisten $RYZB. Könnte den Wert für #Pentixapharm von #EckertundZiegler weiter steigern. #Rayzebio https://t.co/1GmSd9i2RF
California-based #RayzeBio plans to open an R&D site on the northwest side of Indianapolis and hire 64 people, investing $45m into #Indy.
RayzeBio is focused on developing specialty cancer drugs.
#LifeSciences #DevelopIndy @IndyDMD
https://t.co/h68rGfnAhI
$ATNM EV $74M late stage pipeline! Tremendously undervalued The leader in #Radiotherapies #SPCE
#Rayzebio start up raised of $258 million since lunched in August 2020!
@OrbiMed @Venrock @AlexRRosen @WSJVC #VentureCapital

@dkjhaunc @ldtimmerman RayzeBio is start up and long way to go!
@ActiniumPharma $ATNM the leader in #radiotherapy space
1) promising preclinical results presented at #SITC21 Magrolimab + Ac-225 or Lu-177 in Solid tumors & AML the first ever data!
@GileadSciences @abbvie #RayzeBio $GILD $ABBV

@Dyno_Tx, @Roche to tackle #CNS, #liverdisease in #genetherapy #pact.
#RayzeBio debuts with USD 45 Million to target #tumors.
For more details, visit: https://t.co/RXF3Iyg6nB
#healthcare #lifescience #pharmaceutical #biotechnology #market #pharmanews #news #medical #health

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
240.1M followers

Barack Obama 
@barackobama
119.3M followers

Donald J. Trump 
@realdonaldtrump
111.6M followers

Cristiano Ronaldo 
@cristiano
109.1M followers

Narendra Modi 
@narendramodi
106.9M followers

Rihanna 
@rihanna
97.3M followers

NASA 
@nasa
92.1M followers

Justin Bieber 
@justinbieber
90.6M followers

KATY PERRY 
@katyperry
86.9M followers

Taylor Swift 
@taylorswift13
80.7M followers

Lady Gaga 
@ladygaga
72.3M followers

Kim Kardashian 
@kimkardashian
69.4M followers

Virat Kohli 
@imvkohli
68.7M followers

YouTube 
@youtube
68.6M followers

Bill Gates 
@billgates
63.4M followers

The Ellen Show
@theellenshow
62.5M followers

CNN 
@cnn
61.9M followers

Neymar Jr 
@neymarjr
61.3M followers

X 
@x
60.9M followers

Selena Gomez 
@selenagomez
60M followers















